Skip to main content

Table 4 CESM in predicting pCR

From: Predicting response to neo-adjuvant chemotherapy and assessment of residual disease in breast cancer using contrast-enhanced spectral mammography: a combined qualitative and quantitative approach

  Pathologic response
Complete responder Incomplete responder
Count % Count %
RECIST 1.1 evaluation CR 20/21 95.23% 1/60 1.7%
ICR 1/21 4.76% 59/60 98.3%
Combined response evaluation CR 20/21 95.23 1/60 1.7%
ICR 1/21 4.76% 59/60 98.3%